Idioma:

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

Venneti, Sriram ; Dunphy, Mark P ; Zhang, Hanwen ; Pitter, Kenneth L ; Zanzonico, Patrick ; Campos, Carl ; Carlin, Sean D ; La Rocca, Gaspare ; Lyashchenko, Serge ; Ploessl, Karl ; Rohle, Daniel ; Omuro, Antonio M ; Cross, Justin R ; Brennan, Cameron W ; Weber, Wolfgang A ; Holland, Eric C ; Mellinghoff, Ingo K ; Kung, Hank F ; Lewis, Jason S ; Thompson, Craig B

Science translational medicine, 2015-02, Vol.7 (274), p.274ra17-274ra17 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Enviar para

Título:
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Autor: Venneti, Sriram ; Dunphy, Mark P ; Zhang, Hanwen ; Pitter, Kenneth L ; Zanzonico, Patrick ; Campos, Carl ; Carlin, Sean D ; La Rocca, Gaspare ; Lyashchenko, Serge ; Ploessl, Karl ; Rohle, Daniel ; Omuro, Antonio M ; Cross, Justin R ; Brennan, Cameron W ; Weber, Wolfgang A ; Holland, Eric C ; Mellinghoff, Ingo K ; Kung, Hank F ; Lewis, Jason S ; Thompson, Craig B
Assuntos: Blood-Brain Barrier ; Brain Neoplasms - metabolism ; Brain Neoplasms - pathology ; Disease Progression ; Fluorine Radioisotopes - metabolism ; Fluorine Radioisotopes - pharmacokinetics ; Glioma - metabolism ; Glioma - pathology ; Glutamine - metabolism ; Glutamine - pharmacokinetics ; Humans ; Positron-Emission Tomography
É parte de: Science translational medicine, 2015-02, Vol.7 (274), p.274ra17-274ra17
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this study.
Descrição: Glucose and glutamine are the two principal nutrients that cancer cells use to proliferate and survive. Many cancers show altered glucose metabolism, which constitutes the basis for in vivo positron emission tomography (PET) imaging with (18)F-fluorodeoxyglucose ((18)F-FDG). However, (18)F-FDG is ineffective in evaluating gliomas because of high background uptake in the brain. Glutamine metabolism is also altered in many cancers, and we demonstrate that PET imaging in vivo with the glutamine analog 4-(18)F-(2S,4R)-fluoroglutamine ((18)F-FGln) shows high uptake in gliomas but low background brain uptake, facilitating clear tumor delineation. Chemo/radiation therapy reduced (18)F-FGln tumor avidity, corresponding with decreased tumor burden. (18)F-FGln uptake was not observed in animals with a permeable blood-brain barrier or neuroinflammation. We translated these findings to human subjects, where (18)F-FGln showed high tumor/background ratios with minimal uptake in the surrounding brain in human glioma patients with progressive disease. These data suggest that (18)F-FGln is avidly taken up by gliomas, can be used to assess metabolic nutrient uptake in gliomas in vivo, and may serve as a valuable tool in the clinical management of gliomas.
Editor: United States
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 13 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

United States

Buscando em bases de dados remotas. Favor aguardar.